These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 9847389)

  • 1. Characterization of a natural mutation in an antigenic site on the fusion protein of measles virus that is involved in neutralization.
    Fayolle J; Verrier B; Buckland R; Wild TF
    J Virol; 1999 Jan; 73(1):787-90. PubMed ID: 9847389
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Measles Virus Hemagglutinin epitopes immunogenic in natural infection and vaccination are targeted by broad or genotype-specific neutralizing monoclonal antibodies.
    Muñoz-Alía MA; Casasnovas JM; Celma ML; Carabaña J; Liton PB; Fernandez-Muñoz R
    Virus Res; 2017 May; 236():30-43. PubMed ID: 28465158
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antigenic Drift Defines a New D4 Subgenotype of Measles Virus.
    Muñoz-Alía MÁ; Muller CP; Russell SJ
    J Virol; 2017 Jun; 91(11):. PubMed ID: 28356529
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Localization of monoclonal antibody epitopes and functional domains in the hemagglutinin protein of measles virus.
    Hummel KB; Bellini WJ
    J Virol; 1995 Mar; 69(3):1913-6. PubMed ID: 7853533
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contribution of measles virus fusion protein in protective immunity: anti-F monoclonal antibodies neutralize virus infectivity and protect mice against challenge.
    Malvoisin E; Wild F
    J Virol; 1990 Oct; 64(10):5160-2. PubMed ID: 2398539
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antigenic analysis of current wild type and vaccine strains of measles virus.
    Tamin A; Rota PA; Wang ZD; Heath JL; Anderson LJ; Bellini WJ
    J Infect Dis; 1994 Oct; 170(4):795-801. PubMed ID: 7930720
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lentiviral vectors displaying modified measles virus gp overcome pre-existing immunity in in vivo-like transduction of human T and B cells.
    Lévy C; Amirache F; Costa C; Frecha C; Muller CP; Kweder H; Buckland R; Cosset FL; Verhoeyen E
    Mol Ther; 2012 Sep; 20(9):1699-712. PubMed ID: 22617109
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A chimeric alphavirus replicon particle vaccine expressing the hemagglutinin and fusion proteins protects juvenile and infant rhesus macaques from measles.
    Pan CH; Greer CE; Hauer D; Legg HS; Lee EY; Bergen MJ; Lau B; Adams RJ; Polo JM; Griffin DE
    J Virol; 2010 Apr; 84(8):3798-807. PubMed ID: 20130066
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monoclonal antibodies against five structural components of measles virus. I. Characterization of antigenic determinants on nine strains of measles virus.
    Sheshberadaran H; Chen SN; Norrby E
    Virology; 1983 Jul; 128(2):341-53. PubMed ID: 6193632
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Probing neutralizing-antibody responses against emerging measles viruses (MVs): immune selection of MV by H protein-specific antibodies?
    Santibanez S; Niewiesk S; Heider A; Schneider-Schaulies J; Berbers GAM; Zimmermann A; Halenius A; Wolbert A; Deitemeier I; Tischer A; Hengel H
    J Gen Virol; 2005 Feb; 86(Pt 2):365-374. PubMed ID: 15659756
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epitope dampening monotypic measles virus hemagglutinin glycoprotein results in resistance to cocktail of monoclonal antibodies.
    Lech PJ; Tobin GJ; Bushnell R; Gutschenritter E; Pham LD; Nace R; Verhoeyen E; Cosset FL; Muller CP; Russell SJ; Nara PL
    PLoS One; 2013; 8(1):e52306. PubMed ID: 23300970
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular characterization of epitopes on the measles virus hemagglutinin protein.
    Hu A; Sheshberadaran H; Norrby E; Kövamees J
    Virology; 1993 Jan; 192(1):351-4. PubMed ID: 7685966
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A neutralizing antibody prevents postfusion transition of measles virus fusion protein.
    Zyla DS; Della Marca R; Niemeyer G; Zipursky G; Stearns K; Leedale C; Sobolik EB; Callaway HM; Hariharan C; Peng W; Parekh D; Marcink TC; Diaz Avalos R; Horvat B; Mathieu C; Snijder J; Greninger AL; Hastie KM; Niewiesk S; Moscona A; Porotto M; Ollmann Saphire E
    Science; 2024 Jun; 384(6703):eadm8693. PubMed ID: 38935733
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extensive antigenic diversity among human parainfluenza type 2 virus isolates and immunological relationships among paramyxoviruses revealed by monoclonal antibodies.
    Tsurudome M; Nishio M; Komada H; Bando H; Ito Y
    Virology; 1989 Jul; 171(1):38-48. PubMed ID: 2545038
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antigen mimicry involving measles virus hemagglutinin and human respiratory syncytial virus nucleoprotein.
    Norrby E; Sheshberadaran H; Rafner B
    J Virol; 1986 Jan; 57(1):394-6. PubMed ID: 2416956
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Leucine at position 278 of the AIK-C measles virus vaccine strain fusion protein is responsible for reduced syncytium formation.
    Nakayama T; Komase K; Uzuka R; Hoshi A; Okafuji T
    J Gen Virol; 2001 Sep; 82(Pt 9):2143-2150. PubMed ID: 11514723
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of major structural proteins of measles virus with monoclonal antibodies.
    Sato TA; Fukuda A; Sugiura A
    J Gen Virol; 1985 Jul; 66 ( Pt 7)():1397-409. PubMed ID: 2410551
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of measles virus antigens in Streptococcus gordonii.
    Maggi T; Oggioni MR; Medaglini D; Bianchi Bandinelli ML; Soldateschi D; Wiesmüller KH; Muller CP; Valensin PE; Pozzi G
    New Microbiol; 2000 Apr; 23(2):119-28. PubMed ID: 10872681
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protective immunity provided by HLA-A2 epitopes for fusion and hemagglutinin proteins of measles virus.
    Oh S; Stegman B; Pendleton CD; Ota MO; Pan CH; Griffin DE; Burke DS; Berzofsky JA
    Virology; 2006 Sep; 352(2):390-9. PubMed ID: 16781760
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Location of neutralizing epitopes on the fusion protein of Newcastle disease virus strain Beaudette C.
    Yusoff K; Nesbit M; McCartney H; Meulemans G; Alexander DJ; Collins MS; Emmerson PT; Samson AC
    J Gen Virol; 1989 Nov; 70 ( Pt 11)():3105-9. PubMed ID: 2479718
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.